Keywords: Anticoagulants, Averrhoa bilimbi, blood samples, CBC, EDTA, kamias
Advancements in medicine over the last few hundred years have greatly increased the average lifespan of humans all around the world. This is due to the ever-increasing ease of access to tests and procedures that allow people to be informed of their physical wellbeing. One such procedure is the complete blood count (CBC) test, a standard medical procedure that examines a patient’s blood parameters, which serve as markers for health. These counts may be used to diagnose a patient’s disease when studied together with their symptoms, allowing for the creation of a viable treatment plan to address their needs. As such, it is vital that the procedure is made accessible to many.
When conducting CBC tests, blood is drawn from the patient and placed into a tube containing a chemical, called an anticoagulant. Anticoagulants prevent the formation of blood clots that otherwise would render the sample unusable for testing. Various anticoagulants are used depending on the medical context, but Ethylenediaminetetraacetic acid (EDTA) is the primarily used anticoagulant for CBC tests (Banfi et al., 2007).
The Philippines is rich in many types of plants that grow throughout the landscape of the nation. One such plant is Averrhoa bilimbi, known locally as kamias, which is also grown in other tropical countries. It is used in traditional medicine for the treatment of various ailments, such as itches, poisonous animal bites, and syphilis. Studies conducted on a possible use-case of extracted A. bilimbi discovered its capability to prevent blood coagulation, as investigated by Lao (2015) and Sales et al. (2018), in addition to having comparable blood parameters to EDTA when tested. The common limitation of both studies was the inability of A. bilimbi in preserving platelet count, exhibiting a massive decrease upon comparison to EDTA.
This property of kamias makes it a promising alternative anticoagulant; however, to ensure its complete viability as such, it is favorable that A. bilimbi extract preserves all CBC parameters. This study will investigate the addition of a chemical additive to the A. bilimbi extract that, should it counteract the component of the extract that causes a decrease in platelet count, would make A. bilimbi extract a viable alternative anticoagulant comparable to EDTA.
The objective of this research was to modify A. bilimbi extract by introducing additive solutions to the extract to potentially create a more effective alternative anticoagulant.
At which volume of additive solution added to 1 mL of A. bilimbi extract to will the sample remain uncoagulated the longest:
1.1 250 µL;
1.2 500 µL;
1.3 750 µL; and
1.4 1000 µL (1 mL)?
How different are the effects of the modified A. bilimbi extracts, the unmodified A. bilimbi extract, and EDTA to the CBC parameters of the samples, namely:
2.1 Red Blood Cell (RBC);
2.2 Hemoglobin (Hb);
2.3 Hematocrit (Hct);
2.4 White Blood Cell (WBC);
2.5 Neutrophil;
2.6 Eosinophil;
2.7 Lymphocyte;
2.8 Monocyte;
2.9 Platelet count;
2.10 Mean Corpuscular Volume (MCV);
2.11 Mean Corpuscular Hemoglobin (MCH); and
2.12 Mean Corpuscular Hemoglobin Concentration (MCHC)?
How different are the formations observed in the samples treated with the extracts and EDTA in terms of:
3.1 Hemolysis; and
3.2 Rouleaux formation?
Research Design
The researchers will use a quantitative method and an experimental design to collect the data. Quantitative research is typically used to explain and examine a phenomenon. This technique allows the researchers to observe the connections, correlations, and casual connections between variables. Furthermore, the experimental quantitative process relies on the scientific approach. It creates procedures that enable the researchers to test a hypothesis and study the causal connections between variables in a systematic and scientific manner. (Grand Canyon University, 2021).
The A. bilimbi extract from the previous study showed almost similar results with EDTA, with differences only between its white blood cell and platelet count. Given this, the researchers then aimed to modify the extract to make it a more suitable alternative to the standard anticoagulant the researchers used for CBC testing. To achieve this, the researchers extracted A. bilimbi and made it undergo several tests and experiments to ensure its suitability and investigate its properties, thus making the research an experimental type of research.
Research Instrument
The researchers used the fruit of A. bilimbi for the extraction of the fruit. A blender was used, alongside a rudimentary substitute to water bath, and a centrifuge. For the preparations of extracts, the fresh fruits were first washed with distilled water, then peeled to remove overripe or bruised parts. Then, they were blended using a blender, filtered using gauze to remove solid particles, and were then transferred to test tubes. In lieu of a water bath, the test tubes were placed inside a flask filled with hot water, where the tubes were submerged for at least 30 minutes. A temperature of around 70ºC was maintained by putting in hot water from an electric kettle and removing cooled water using a syringe. These were then centrifuged for 10 mins, and filtered using Whatman no. 1 filter paper. To store it until CBC could be performed, it was frozen.
Testing of CBC and neutralizing the acidity of the fruit extract is the critical part of this research in order to identify if the additives made a difference to the blood’s CBC parameters. The previous study shows that slight hemolysis was observed after the extract was centrifuged, caused by its acidity (Dizon et al., 2024); as such, the researchers aim to neutralize the extract to prevent hemolysis. The researchers used sodium hydroxide and potassium hydroxide with sodium fluoride as neutralizing agents to prevent these effects. The additive extract was applied to 1 mL of A. bilimbi extract in the ranges of 0.25, 0.5, 0.75, and 1 mL additive. This resulting modified extract was then applied to 1 mL of blood, which was done to investigate differences in anticoagulative ability based on the amount of extract applied.
Data Gathering Procedure
First, the researchers wrote a formal permission letter to use the laboratory. Following this, the researchers purchased one kilogram of A. bilimbi. Second, the researchers used the procedure of their prior study (Dizon et al., 2024), which was adapted from Sales et al. (2018). Third, the researchers took a few test runs by adding the mentioned solutions to the A. bilimbi extract and observing it through the microscope. This was done to monitor for improvements in the anticoagulative ability of the extract, and in preventing formation of hemolysis and rouleaux formation. Fourth, the researchers, having prior established a relationship with chosen diagnostic clinic ACE Diagnostics Valenzuela, corresponded and established a schedule for experimentation of the study. Fifth, the clinic aided the researchers for the experimentation and testing of the study. The researchers performed titration on the extract until it achieved the desired neutral pH level of the extract. The researchers then had their blood drawn to be used for testing the extract. The data from these tests was then collected. After the observation, the researchers summarized and interpreted the data.
Clotting time of modified A. bilimbi extract
Table 1: Clotting time of modified A. bilimbi extract, by volume of additive added to extract, trial 1
All samples treated with modified A. bilimbi extract, regardless of additive solution, coagulated within 2-4 minutes. Extracts with higher ratios of A. bilimbi and additives exhibited slightly extended clotting times, but did not prevent coagulation altogether. pH levels of the additive were very alkaline at pH 13-14 for sodium hydroxide solution, and pH 12-13 for potassium hydroxide solution, but mixing with the extract yielded very acidic extracts, ranging around pH 1-1.5. A. bilimbi extract added with saline did not aid in preventing coagulation, and all clotted close to one another. This renders samples treated with any of the three additives unfit for CBC testing.
Table 2: Clotting time of modified A. bilimbi extract, by volume of additive added to extract, trial 2
For the second trial, the same setup was tested, creating another set of modified extracts with the same procedure as previously performed, with the same parameters. This is done to ensure that the results are similar.
While there were slight variations in clotting time compared to the first trial, all samples still ended up clotting within 2-4 minutes, similar to the first trial. A. bilimbi extract added with saline still did not help in stopping clot formation, and all samples treated as such coagulated quickly.
Table 3: Clotting time of sodium hydroxide-modified A. bilimbi extract, trial 3
For the second trial, the same setup was tested, creating another set of modified extracts with the same procedure as previously performed, with the same parameters. This is done to ensure that the results are similar.
While there were slight variations in clotting time compared to the first trial, all samples still ended up clotting within 2-4 minutes, similar to the first trial. A. bilimbi extract added with saline still did not help in stopping clot formation, and all samples treated as such coagulated quickly.
Difference in the effects of modified A. bilimbi extracts, unmodified A. bilimbi extract, and EDTA to the CBC parameters of blood samples
Table 4. CBC test comparison of unmodified A. bilimbi extract and EDTA
The examination of CBC parameters of a blood sample requires that it remains uncoagulated before it can be centrifuged and analyzed. However, because the results showed that samples treated with the modified extracts could not prevent coagulation, it is impossible to know whether or not they effectively preserve blood parameters. Following this, the researchers performed CBC testing on the unmodified A. bilimbi extract and EDTA to provide a comparison between the two.
As established in previous studies, most parameters, save for platelet count, were close to the amounts that came from EDTA testing. WBC count was much closer to the expected value compared to the researcher’s prior study (Dizon et al., 2024).
The difference of the formations observed in blood treated by A. bilimbi extract compared to the other extracts
Hemolysis and rouleaux formation are two of the formations in blood that manifested in the previous study of the researchers (Dizon et al., 2024). Hemolysis is observed as a light red liquid floating above the dark blood after a sample is centrifuged. Rouleaux formation, on the other hand, is observed when the samples are examined under a microscope, where the red blood cells resemble stacked coins. The observation of such formations may only be done with procedures that require uncoagulated blood samples, which the modified extracts were unable to yield.
Hemolysis is linked with pH level; the introduction of an acidic extract into the blood spurred on its formation, as in the researcher’s prior study (Dizon et al., 2024) and as stated in Ivanov (1999). Thus, the study aimed to neutralize the extract by mixing it with additives that reacted with oxalic acid, turning it into oxalate. However, regardless of the ratio added, the acid content of A. bilimbi extract far overpowered even the most alkaline additive solutions. When applied to A. bilimbi extract, pH levels dramatically dropped to at most pH 2. Whether the pH level of the extract was neutralized or not, as the samples clotted, hemolysis would be unable to be checked.
Conclusion
The chemicals that were used in an attempt to neutralize the acidity of A. bilimbi, namely sodium hydroxide, potassium hydroxide, and sodium fluoride, may have interfered with the mechanism of A. bilimbi that causes anticoagulation, making them unfit as additives. This is because blood samples treated with modified A. bilimbi extract clotted within 2-4 minutes, making them unsuitable for CBC testing, unlike samples treated with unmodified A. bilimbi extract.
None of the CBC parameters were preserved by the modified A. bilimbi extract, as all samples treated with it clotted. Unmodified A. bilimbi extract remains more in line with EDTA, except for in platelet count, akin to findings of similar previous studies (Lao, 2015; Sales et al., 2018). WBC count is better preserved by unmodified A. bilimbi extract in this trial than the researcher’s previous trial (Dizon et al., 2024).
Even with very alkaline solutions reaching up to pH level 14, the introduction of additives to A. bilimbi extract could not neutralize the acidity of the oxalic acid. Modified A. bilimbi extract still has a pH level of 1-2, similar to unmodified A. bilimbi extract, regardless of the alkalinity of the applied additive. Thus, the appearance of these formations could not be stopped by the modified extract.
Agnello, L., Giglio, R. V., Bivona, G., Scazzone, C., Gambino, C. M., Iacona, A., Ciaccio, A. M., Lo Sasso, B., & Ciaccio, M. (2021). The value of a complete blood count (CBC) for sepsis diagnosis and prognosis. Diagnostics (Basel, Switzerland), 11(10), 1881. https://doi.org/10.3390/diagnostics11101881
Ahmed, M. M., Ghauri, S. K., Javaeed, A., Rafique, N., Hussain, W., & Khan, N. (2020). Trends of utilization of complete blood count parameters for patient management among doctors in Azad Kashmir. Pakistan Journal of Medical Sciences, 36(5), 999.
Alhassan, A. M., & Ahmed, Q. U. (2016). Averrhoa bilimbi Linn.: A review of its ethnomedicinal uses, phytochemistry, and pharmacology. Journal of pharmacy & bioallied sciences, 8(4), 265–269.
Banfi, G., Salvagno, G. & Lippi, G. (2007). The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes [Abstract]. Clinical chemistry and laboratory medicine, 45(5), 565–576. https://doi.org/10.1515/CCLM.2007.110
Bayot, M. L., & Tadi, P. (2023, August 8). Laboratory Tube collection. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK555991/
Daud, N., Hashim, H., & Samsulrizal, N. (2013). Anticoagulant activity of Averrhoa bilimbi Linn in normal and Alloxan-induced diabetic rats. The Open Conference Proceedings Journal, 4(1), 21–26.
Dizon, M. D., Javier, C. J., Reyes, N. M., Pancho, S. K., Pastoral, G. K., Malong, S. I. J., Sumadsad, E. G., Cariloria, J. L. (2024). Determination and comparison of the anticoagulative effects of Averrhoa bilimbi and Averrhoa carambola to standard anticoagulant [Unpublished manuscript].
Honorato, R., Rojas, C., & Ivanovic, N. (1948). Sodium oxalate as anticoagulant. Experimental Biology and Medicine, 68(2), 300–301. https://doi.org/10.3181/00379727-68-16463p
Grand Canyon University. (2021, November 22). Types of quantitative research methods and designs. GCU. https://www.gcu.edu/blog/doctoral-journey/types-quantitative-research-methods-designs
Ivanov, I. T. (1999). Low pH-induced hemolysis of erythrocytes is related to the entry of the acid into cytosole and oxidative stress on cellular membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes, 1415(2), 349-360. https://doi.org/10.1016/s0005-2736(98)00202-8
Kee, N. L. A., Mnonopi, N., Davids, H., Naudé, R. J., & Frost, C. L. (2008). Antithrombotic/anticoagulant and anticancer activities of selected medicinal plants from South Africa. African Journal of Biotechnology, 7(3).
Lao, M. B. C. (2017). Hematologic effects of Averrhoa bilimbi (Kamias) ethanolic fruit extract. International Journal of Education Research for Higher Learning, 23(2), 181–190.
Lima, V. L. A. G. D., Mélo, E. D. A., & Santos Lima, L.D. (2001). Physicochemical characteristics of bilimbi (Averrhoa bilimbi L.). Revista Brasileira de Fruticultura, 23, 421-423.
Lima-Oliveira, G., Brennan-Bourdon, L. M., Varela, B., Arredondo, M. E., Aranda, E., Flores, S., & Ochoa, P. (2021). Clot activators and anticoagulant additives for blood collection [Abstract]. A critical review on behalf of COLABIOCLI WG-PRE-LATAM. Critical Reviews in Clinical Laboratory Sciences, 58(3).
Nipuna, H. (n.d.). Oxalic acid and sodium hydroxide reaction | H2C2O4 + NaOH. https://www.chemistryscl.com/reactions/oxalic-acid-and-sodium-hydroxide-reaction-H2C2O4+NaOH/index.php
Peksöz, R., & Bayar, B. (2021). The role of complete blood count parameters in diagnosing acute appendicitis and measuring the severity of inflammation. Ulusal Travma Ve Acil Cerrahi Dergisi-Turkish Journal Of Trauma & Emergency Surgery, 27(6).
Punčochář, M. (n.d.). H2C2O4 + 2 KOH → K2C2O4 + 2 H2O - Balanced equation | Chemical Equations online! Michal Punčochář. https://chemequations.com/en/?s=H2C2O4+%2B+KOH+%3D+K2C2O4+%2B+H2O
Sales, M.E., Andaya, A.J., & Maylas, P.D. (2018). Averrhoa bilimbi extract as an alternative anticoagulant for manual complete blood count. Journal of Health Sciences, 1(1), 39–42.
Seo, I. H., & Lee, Y. J. (2022). Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: a comprehensive literature review. Biomedicines, 10(11), 2697